Price of water & corporate sustainability agendas pushing waste reuse; Veolia

By Nick Taylor

- Last updated on GMT

The price of water and corporate agendas are driving pharmaceutical production plants to reuse and reclaim waste, Veolia said.

A desire to make manufacturing more efficient while meeting environmental standards in corporate agendas is leading some drugmakers to reconsider waste handling at their existing production plants. Veolia Water Solutions and Technologies is working with some of these businesses, such as Roche.

We did some revamping of an existing plant to produce energy, biogas in fact, from an effluent. And this biogas is used as an energy source for the facility,” ​Johann Bonnet, strategic account manager at Veolia, told in-PharmaTechnologist.com.

Related news

Show more

Related products

Solution for challenging antibodies – Planova™ S20N

Solution for challenging antibodies – Planova™ S20N

Content provided by Asahi Kasei Medical Co., Ltd. | 24-Sep-2024 | White Paper

Designed as a next generation cellulose-based virus removal filter, Planova™ S20N has demonstrated robust filtration performance for challenging molecules...

Efficient Freezing & Storage of Biopharmaceuticals

Efficient Freezing & Storage of Biopharmaceuticals

Content provided by Single Use Support | 06-Nov-2023 | White Paper

Various options exist for freezing biopharmaceutical bulk material, but selecting the most effective and efficient approach for each cold chain can be...

Follow us

Products

View more

Webinars